Topical use of immunosupressor,Tacrolimus, in desquamative gingivitis patients: an open trial.
Use of topical immunosupressant,Tacrolimus, in desquamative gingivitis patients: evaluation of effectiveness according to individual and disease characteristics.
University of Sao Paulo
20 participants
Sep 1, 2008
Interventional
Conditions
Summary
The main purpose of this trial is to assess the therapeutic efficacy of tacrolimus, in topical use, to the symptomatic treatment of desquamative gingivitis.
Eligibility
Inclusion Criteria2
- Patients exhibiting desquamative gingivitis with consent agreement.
- There will be no exclusion by gender, age, or race, only if the patient is carrying a change of renal or hepatic
Exclusion Criteria1
- the patient with renal failure and / or liver
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The patient will be shaped to get a plate of silicon on top of the model study, after will be delivered promptly to the patient with a tube of medication with Tacrolimus 0.1% gel, the patient will be guided in making the application through the trays that have the gel in it and take position in the mouth for 5 minutes twice a day for 90 days.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12609000125224